GE HealthCare CTO has 2,940 shares withheld

Q: Was the GEHC insider transaction an open-market sale or a tax withholding?

The transactions were tax-withholding dispositions. Shares of GE HealthCare common stock were withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units, rather than being sold in the open market.

Q: How many GEHC shares were withheld in each transaction reported by the CTO?

Two transactions were reported: one for 1,644 shares and another for 1,296 shares of GE HealthCare common stock. Both occurred on September 1, 2026 and were classified as code F transactions for tax withholding.

Q: Were the GEHC insider transactions made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not checked, and there is no footnote stating that the transactions were made pursuant to a Rule 10b5-1 trading plan or similar pre-arranged trading arrangement.

Q: What is the nature of the securities involved in the GEHC Form 4 filing?

The securities involved are Common Stock, par value $0.01 per share, of GE HealthCare Technologies Inc. The shares were withheld to cover tax obligations triggered by the vesting of restricted stock units held by the chief technology officer.

GE HealthCare Technologies Inc. (GEHC) reported that Chief Technology Officer Taha Kass-Hout had shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations arising from the vesting of restricted stock units.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. (GEHC) reported that Chief Technology Officer Taha Kass-Hout had shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations arising from the vesting of restricted stock units.

Two code F transactions were reported, covering 1,644 and 1,296 shares at $71.23 per share, for a total of 2,940 shares delivered or withheld for payment of tax liability. No Rule 10b5-1 trading plan is indicated for these transactions.

Insider Trade Summary

Tax Withholding: 2,940 shares

Tax Withholding 2 txns

Insider Kass-Hout Taha

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock, par value $0.01 per share ^F1	1,644	$71.23	$117K
Tax Withholding	Common Stock, par value $0.01 per share ^F1	1,296	$71.23	$92K

Holdings After Transaction: Common Stock, par value $0.01 per share — 89,969 shares (Direct)

Footnotes (1)

F1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Key Figures

Shares withheld (first transaction): 1,644 shares Shares withheld (second transaction): 1,296 shares Total shares withheld for tax: 2,940 shares +1 more

4 metrics

Shares withheld (first transaction) 1,644 shares Code F tax-withholding disposition on September 1, 2026

Shares withheld (second transaction) 1,296 shares Code F tax-withholding disposition on September 1, 2026

Total shares withheld for tax 2,940 shares Sum of two code F transactions for tax withholding

Per-share value used for withholding $71.23 per share Applied to both tax-withholding transactions on September 1, 2026

Key Terms

restricted stock units, tax withholding obligations, Code F transaction

3 terms

restricted stock units financial

"obligations in connection with the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"common stock to satisfy tax withholding obligations in connection"

Code F transaction financial

"Payment of tax liability by delivering or withholding securities"

FAQ

What insider transaction did GEHC’s chief technology officer report on this Form 4?

The Form 4 reports that GE HealthCare’s chief technology officer, Taha Kass-Hout, had 2,940 shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock units.

Was the GEHC insider transaction an open-market sale or a tax withholding?

The transactions were tax-withholding dispositions. Shares of GE HealthCare common stock were withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units, rather than being sold in the open market.

How many GEHC shares were withheld in each transaction reported by the CTO?

Two transactions were reported: one for 1,644 shares and another for 1,296 shares of GE HealthCare common stock. Both occurred on September 1, 2026 and were classified as code F transactions for tax withholding.

At what price were the GEHC shares valued for the CTO’s tax withholding?

For both transactions, the GE HealthCare shares used for tax withholding were valued at $71.23 per share. This price applies to the 1,644 and 1,296 shares withheld to cover tax obligations on vested restricted stock units.

Were the GEHC insider transactions made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not checked, and there is no footnote stating that the transactions were made pursuant to a Rule 10b5-1 trading plan or similar pre-arranged trading arrangement.

What is the nature of the securities involved in the GEHC Form 4 filing?

The securities involved are Common Stock, par value $0.01 per share, of GE HealthCare Technologies Inc. The shares were withheld to cover tax obligations triggered by the vesting of restricted stock units held by the chief technology officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/03/2026 - 04:28 PM Accepted by SEC EDGAR 09/03/2026 - 04:18 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kass-Hout Taha

(Last)

(First)

(Middle)

500 W. MONROE STREET

(Street)

CHICAGO

ILLINOIS

60661

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	09/01/2026		F		1,644⁽¹⁾	D	$71.23	91,265	D
Common Stock, par value $0.01 per share	09/01/2026		F		1,296⁽¹⁾	D	$71.23	89,969	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR